A certain stamp of approval…NLT SPINE has announced that it was recently selected as a Red Herring Top 100 award winner. The list of winners represents Europe’s leading private companies and startups, with innovative technologies across their respective industries.
NLT SPINE: Red Herring Award Winner
1 min read Premium comments
Secondary
“Selecting startups that show the most potential for disruption and growth is never easy, ” said Alex Vieux, publisher and CEO of Red Herring, Inc., in the April 23, 2013 news release. “We looked at hundreds and hundreds of candidates from all across the continent, and after much thought and debate, narrowed the list down to the Top 100 Winners. Each year, the competition gets tougher but we believe NLT SPINE demonstrates the vision, drive and innovation that define a Red Herring winner.”
NLT SPINE has developed the “non-linear” technology platform enabling implantation of large spinal implants and instruments through small incisions for the treatment of degenerative conditions of the spine. With the “non-linear” technology platform, which is applicable to a wide variety of surgical spine procedures, implant and instrument size is not limited by the incision size.
Red Herring’s editorial staff evaluated the companies on both quantitative and qualitative criteria, such as financial performance, technological innovation, management quality, overall business strategy and market penetration. This assessment was complemented by a review of the track records and standings of similar startups in the same verticals, allowing Red Herring to see past the “buzz” and make the list a valuable instrument of discovery and advocacy for the most promising new business models in Europe.
Didier Toubia, CEO of NLT SPINE, told OTW, “To be included in the company of many great technologies that have received Red Herring awards in the past, makes all of us at NLT SPINE, very proud. Each recognition the company receives reinforces the team’s confidence in our innovative products and technologies and increases the motivation to continue developing unique solutions for the spinal market.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.